Sales & Marketing News | pharmaphorum

News

Sobi bolsters blood division via $435m ADC licensing deal

Swedish rare disease specialist Sobi is paying $55 million upfront to license rights to ADC Therapeutics' lymphoma therapy Zynlonta – approved in the US last year – in Europe and other inte

News

AbbVie shielded profits from tax, says Senate panel

A report by the Senate Finance Committee has concluded that AbbVie exploited a financial loophole introduced by former President Donald Trump in 2017 to avoid paying "billions in taxes."

News

Merck in "advanced talks" for $40bn Seagen bid; report

The rumour that Merck & Co is preparing to make a sizeable offer to buy cancer specialist Seagen won't go away.

News

BioNTech bites back after CureVac patent challenge

BioNTech has responded to a patent infringement lawsuit filed by fellow German biotech CureVac over its COVID-19 vaccine, saying it will "vigorously" defend itself.

News

Packaged Pills in aluminium blisters stacked on each other

Big three distributors claim win in $2.5bn WV opioid case

A court in West Virginia has ruled that US drug distributors McKesson, AmerisourceBergen and Cardinal Health are not responsible for fuelling the opioid crisis that has claimed thousands of

News

Sanofi makes low-cost medicines pledge for low-income countr...

Sanofi has said it will make 30 of its most commonly prescribed medicines available at non-profit prices to 40 lower-income countries, as part of a global health initiative launched by the

Sobi bolsters blood division via $435m ADC licensing deal

AbbVie shielded profits from tax, says Senate panel

Merck in "advanced talks" for $40bn Seagen bid; report

BioNTech bites back after CureVac patent challenge

Big three distributors claim win in $2.5bn WV opioid case

Sanofi makes low-cost medicines pledge for low-income countr...

On the benefits of earlier oncological intervention, with Jo...

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks